Effect of Ketogenic Diets on Cardio-Metabolic Outcomes in Cancer Patients: A Systematic Review and Meta-Analysis of Controlled Clinical Trials

References

• Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–14. doi:10.1126/science.123.3191.309
   PubMed Web of Science ®Google Scholar
• Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325–37. doi:10.1038/nrc3038.
   PubMed Web of Science ®Google Scholar
• Gatenby R, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4(11):891–9. doi:10.1038/nrc1478.
   PubMed Web of Science ®Google Scholar
• Marín-Hernández A, Rodríguez-Enríquez S, Vital-González PA, Flores-Rodríguez FL, Macías-Silva M, Sosa-Garrocho M, Moreno-Sánchez R. Determining and understanding the control of glycolysis in fast-growth tumor cells: Flux control by an over-expressed but strongly product-inhibited hexokinase. Febs J. 2006;273(9):1975–88. doi:10.1111/j.1742-4658.2006.05214.x.
   PubMed Web of Science ®Google Scholar
• Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E. Energy metabolism in tumor cells. Febs J. 2007;274(6):1393–418. doi:10.1111/j.1742-4658.2007.05686.x.
   PubMed Web of Science ®Google Scholar
• Bowers LW, Rossi EL, O’Flanagan CH, deGraffenried LA, Hursting SD. The role of the insulin/IGF system in cancer: lessons learned from clinical trials and the energy balance-cancer link. Front Endocrinol (Lausanne). 2015;6:77. doi:10.3389/fendo.2015.00077.
   PubMed Web of Science ®Google Scholar
• Klement RJ, Fink MK. Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer. Oncogenesis. 2016;5:e193. doi:10.1038/oncsis.2016.2.
   PubMed Web of Science ®Google Scholar
• Yancy WS, Foy M, Chalecki AM, Vernon MC, Westman EC. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab. 2005;2:34. doi:10.1186/1743-7075-2-34
   Google Scholar
• Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013;67(8):789–96. doi:10.1038/ejcn.2013.116.
   PubMed Web of Science ®Google Scholar
• Neal EG. Ketogenic dietary therapy for epilepsy and other disorders: current perspectives. NDS. 2014;6:25–33. doi:10.2147/NDS.S41517
   Google Scholar
• Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, Westman EC, Accurso A, Frassetto L, Gower BA, McFarlane SI, et al. Dietary Carbohydrate restriction as the first approach in diabetes management. Critical review and evidence base. Nutrition. 2015;31(1):1–13. doi:10.1016/j.nut.2014.06.011.
   PubMed Web of Science ®Google Scholar
• McDonald TJW, Cervenka MC. Ketogenic Diets for Adult Neurological Disorders. Neurotherapeutics. 2018;15(4):1018–31. doi:10.1007/s13311-018-0666-8.
   PubMed Web of Science ®Google Scholar
• Fraser DA, Thoen J, Bondhus S, Haugen M, Reseland JE, Djoseland O, et al. Reduction in serum leptin and IGF-1 but preserved T-lymphocyte numbers and activation after a ketogenic diet in rheumatoid arthritis patients. Clin Exp Rheumatol. 2000;18:209–14.
   PubMed Web of Science ®Google Scholar
• Volek JS, Sharman MJ, Jeff S. Cardiovascular and Hormonal aspects of very-low-carbohydrate ketogenic diets. Obes Res. 2004;12(S11):115S–23S. doi:10.1038/oby.2004.276
   PubMedGoogle Scholar
• Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med. 2005;142(6):403–12. doi:10.7326/0003-4819-142-6-200503150-00006.
   PubMed Web of Science ®Google Scholar
• Wright C, Simone NL. Obesity and tumor growth: inflammation, immunity, and the role of a ketogenic diet. Curr Opin Clin Nutr Metab Care. 2016;19(4):294–9. doi:10.1097/MCO.0000000000000286.
   PubMed Web of Science ®Google Scholar
• Khodabakhshi A, Mahmoudi M, Majd HM, Davoodi H. Possible nutrition-related mechanisms of metabolic management in cancer treatment. Int J Cancer Manag. 2021;14(1):e107678. doi:10.5812/ijcm.107678
   Web of Science ®Google Scholar
• Fredericks M, Ramsey RB. 3-Oxo acid coenzyme A transferase activity in brain and tumors of the nervous system. J Neurochem. 1978;31(6):1529–31. doi:10.1111/j.1471-4159.1978.tb06581.x
   PubMed Web of Science ®Google Scholar
• Tisdale MJ, Brennan RA. Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues. Br J Cancer. 1983;47(2):293–7. doi:10.1038/bjc.1983.38
   PubMed Web of Science ®Google Scholar
• Skinner R, Trujillo A, Ma X, Beierle EA. Ketone bodies inhibit the viability of human neuroblastoma cells. J Pediatr Surg. 2009;44(1):212–6. doi:10.1016/j.jpedsurg.2008.10.042
   PubMed Web of Science ®Google Scholar
• Maurer GD, Brucker DP, Bähr O, Harter PN, Hattingen E, Walenta S, Mueller-Klieser W, Steinbach JP, Rieger J. Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. BMC Cancer. 2011;11:315. doi:10.1186/1471-2407-11-315.
   PubMed Web of Science ®Google Scholar
• Allen BG, Bhatia SK, Buatti JM, Brandt KE, Lindholm KE, Button AM, Szweda LI, Smith BJ, Spitz DR, Fath MA. Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clin Cancer Res. 2013;19(14):3905–13. doi:10.1158/1078-0432.CCR-12-0287
   PubMed Web of Science ®Google Scholar
• Allen BG, Bhatia SK, Anderson CM, Eichenberger-Gilmore JM, Sibenaller ZA, Mapuskar KA, Schoenfeld JD, Buatti JM, Spitz DR, Fath MA. Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism. Redox Biol. 2014;2:963–70. doi:10.1016/j.redox.2014.08.002.
   PubMed Web of Science ®Google Scholar
• Klement RJ. The influence of ketogenic therapy on the 5 R’s of radiobiology. Int J Radiat Biol. 2019;95(4):394–407. doi:10.1080/09553002.2017.1380330.
   PubMed Web of Science ®Google Scholar
• Khodabakhshi A, Akbari ME, Mirzaei HR, Seyfried TN, Kalamian M, Davoodi SH. Effects of Ketogenic metabolic therapy on patients with breast cancer: A randomized controlled clinical trial. Clin Nutr. 2021;40(3):751–8. doi:10.1016/j.clnu.2020.06.028
   PubMed Web of Science ®Google Scholar
• Kämmerer U, Klement RJ, Joos FT, Sütterlin M, Reuss-Borst M. Low carb and ketogenic diets increase quality of life, physical performance, body composition, and metabolic health of women with breast cancer. Nutrients. 2021;13(3):1029. doi:10.3390/nu13031029
   PubMed Web of Science ®Google Scholar
• Klement RJ, Champ CE, Kämmerer U, Koebrunner PS, Krage K, Schäfer G, Weigel M, Sweeney RA. Impact of a ketogenic diet intervention during radiotherapy on body composition: III—final results of the KETOCOMP study for breast cancer patients. Breast Cancer Res. 2020;22(1):94. doi:10.1186/s13058-020-01331-5
   PubMed Web of Science ®Google Scholar
• Klement RJ, Weigel MM, Sweeney RA. A ketogenic diet consumed during radiotherapy improves several aspects of quality of life and metabolic health in women with breast cancer. Clin Nutr. 2021;40(6):4267–74. doi:10.1016/j.clnu.2021.01.023
   Web of Science ®Google Scholar
• Klement RJ, Koebrunner PS, Meyer D, Kanzler S, Sweeney RA. Impact of a ketogenic diet intervention during radiotherapy on body composition: IV. Final results of the KETOCOMP study for rectal cancer patients. Clin Nutr. 2021;40(7):4674–84. doi:10.1016/j.clnu.2021.05.015
   PubMed Web of Science ®Google Scholar
• Klement RJ, Meyer D, Kanzler S, Sweeney RA. Ketogenic diets consumed during radio‑chemotherapy have beneficial effects on quality of life and metabolic health in patients with rectal cancer. Eur J Nutr. 2022;61(1):69–84. doi:10.1007/s00394-021-02615-y
   PubMed Web of Science ®Google Scholar
• Freedland SJ, Allen J, Jarman A, Oyekunle T, Armstrong AJ, Moul JW, Sandler HM, Posadas E, Levin D, Wiggins E, et al. A Randomized controlled trial of a 6-month low-carbohydrate intervention on disease progression in men with recurrent prostate cancer: Carbohydrate and prostate study 2 (CAPS2). Clin Cancer Res. 2020;26(12):3035–43. doi:10.1158/1078-0432.CCR-19-3873
   PubMed Web of Science ®Google Scholar
• Voss M, Wagner M, von Mettenheim N, Harter PN, Wenger KJ, Franz K, Bojunga J, Vetter M, Gerlach R, Glatzel M, et al. ERGO2: a prospective, randomized trial of calorie-restricted ketogenic diet and fasting in addition to reirradiation for malignant glioma. Int J Radiat Oncol Biol Phys. 2020;108(4):987–95. doi:10.1016/j.ijrobp.2020.06.021
   PubMed Web of Science ®Google Scholar
• Yang Y-F, Mattamel PB, Joseph T, Huang J, Chen Q, Akinwunmi BO, Zhang CJP, Ming W-K. Efficacy of low-carbohydrate ketogenic diet as an adjuvant cancer therapy: A systematic review and meta-analysis of randomized controlled trials. Nutrients. 2021;13(5):1388. doi:10.3390/nu13051388
   PubMed Web of Science ®Google Scholar
• The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. 2nd ed. Oxford: Wiley Blackwell; 2019.
   Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13. doi:10.1186/1471-2288-5-13
   PubMedGoogle Scholar
• Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi:10.1186/1471-2288-14-135.
   PubMed Web of Science ®Google Scholar
• Ramírez A, Cox C. Improving on the range rule of thumb. Rose-Hulman Undergrad Math. J. 2012;13(2):1.
   Google Scholar
• Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, MJ P, et al. editors. Cochrane Handbook for systematic reviews of interventions. 6.2. Cochrane; 2021. Available from www.training.cochrane.org/handbook
   Google Scholar
• Held L, Ott M. On p-values and bayes factors. Annu. Rev. Stat. Appl. 2018;5(1):393–419. doi:10.1146/annurev-statistics-031017-100307
   Web of Science ®Google Scholar
• Furukawa K, Shigematus K, Iwase Y, Mikami W, Hoshi H, Nishiyama T, Ohtuka A, Abe H. Clinical effects of one year of chemotherapy with a modified medium-chain triglyceride ketogenic diet on the recurrence of stage IV colon cancer. JCO. 2018;36(15_suppl)abstr:e15709–e15709. doi:10.1200/JCO.2018.36.15_suppl.e15709
   Web of Science ®Google Scholar
• Artzi M, Liberman G, Vaisman N, Bokstein F, Vitinshtein F, Aizenstein O, Ben Bashat D. Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study. J Neurooncol. 2017;132(2):267–75. doi:10.1007/s11060-016-2364-x.
   PubMed Web of Science ®Google Scholar
• Furukawa K, Shigematsu K, Iwase Y, Mikami W, Hoshi H, Nishiyama T, et al. Clinical effects of 1 year of chemotherapy with a modified medium-chain triglyceride ketogenic diet on the recurrence of stage IV colon cancer. J Japanese Soc Parenter Enter Nutr. 2018;33:1139–46. doi:10.11244/jspen.33.1139.
   Google Scholar
• Santos JG, Faria G, Da Cruz Souza Da Cruz W, Fontes CA, Schönthal AH, Quirico-Santos T, et al. Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy. Surg Neurol Int. 2020;11:1–7. doi:10.25259/SNI_445_2020
   PubMedGoogle Scholar
• Chi J-T, Lin P-H, Tolstikov V, Oyekunle T, Alvarado GCG, Ramirez-Torres A, Chen EY, Bussberg V, Chi B, Greenwood B, et al. The influence of low-carbohydrate diets on the metabolic response to androgen-deprivation therapy in prostate cancer. Prostate. 2021;81(10):618–28. doi:10.1002/pros.24136.
   PubMed Web of Science ®Google Scholar
• Cohen C, Fontaine K, Arend R, Soleymani T, Gower B. Favorable effects of a ketogenic diet on physical function, perceived energy, and food cravings in women with ovarian or endometrial cancer: a randomized, controlled trial. Nutrients. 2018;10(9):1187. doi:10.3390/nu10091187
   PubMed Web of Science ®Google Scholar
• Zorn S, Ehret J, Schäuble R, Rautenberg B, Ihorst G, Bertz H, Urbain P, Raynor A. Impact of modified short-term fasting and its combination with a fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer patients - a controlled cross-over pilot study. BMC Cancer. 2020;20(1):578. doi:10.1186/s12885-020-07041-7.
   PubMed Web of Science ®Google Scholar
• Wenger KJ, Wagner M, Harter PN, Franz K, Bojunga J, Fokas E, Imhoff D, Rödel C, Rieger J, Hattingen E, et al. Maintenance of energy homeostasis during calorically restricted ketogenic diet and fastingmr-spectroscopic insights from the ergo2 trial. Cancers (Basel). 2020;12(12):3549. doi:10.3390/cancers12123549
   PubMed Web of Science ®Google Scholar
• Freedland SJ, Howard L, Allen J, Smith J, Stout J, Aronson W, Inman BA, Armstrong AJ, George D, Westman E, et al. A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial. Prostate Cancer Prostatic Dis. 2019;22(3):428–37. doi:10.1038/s41391-019-0126-5
   PubMed Web of Science ®Google Scholar
• Martin-McGill KJ, Marson AG, Tudur Smith C, Young B, Mills SJ, Cherry MG, Jenkinson MD. Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study. J Neurooncol. 2020;147(1):213–27. doi:10.1007/s11060-020-03417-8.
   PubMed Web of Science ®Google Scholar
• Cohen CW, Fontaine KR, Arend RC, Alvarez RD, Leath III CA, Huh WK, Bevis KS, Kim KH, Straughn JM, Gower BA. A Ketogenic diet reduces central obesity and serum insulin in women with ovarian or endometrial cancer. J Nutr. 2018;148(8):1253–60. doi:10.1093/jn/nxy119
   PubMed Web of Science ®Google Scholar
• Cohen CW, Fontaine KR, Arend RC, Gower BA. A ketogenic diet is acceptable in women with ovarian and endometrial cancer and has no adverse effects on blood lipids: a randomized, controlled trial. Nutr Cancer. 2020;72(4):584–94. doi:10.1080/01635581.2019.1645864.
   PubMed Web of Science ®Google Scholar
• Klement RJ, Schäfer G, Sweeney RA. A ketogenic diet exerts beneficial effects on body composition of cancer patients during radiotherapy: An interim analysis of the KETOCOMP study. J Tradit Complement Med. 2020;10(3):180–7. doi:10.1016/j.jtcme.2019.03.007.
   PubMedGoogle Scholar
• Klement RJ, Sweeney RA. Impact of a ketogenic diet intervention during radiotherapy on body composition: V. Final results of the KETOCOMP study for head and neck cancer patients. Strahlenther Onkol. 2022; doi:10.1007/s00066-022-01941-2. 35499696
   PubMed Web of Science ®Google Scholar
• Khodabakhshi A, Akbari ME, Mirzaei HR, Mehrad-Majd H, Kalamian M, Davoodi SH. Feasibility, safety, and beneficial effects of mct-based ketogenic diet for breast cancer treatment: a randomized controlled trial study. Nutr Cancer. 2020;72(4):627–34. doi:10.1080/01635581.2019.1650942.
   PubMed Web of Science ®Google Scholar
• Khodabakhshi A, Seyfried TN, Kalamian M, Beheshti M, Davoodi SH. Does a ketogenic diet have beneficial effects on quality of life, physical activity or biomarkers in patients with breast cancer: a randomized controlled clinical trial. Nutr J. 2020;19(1):87. doi:10.1186/s12937-020-00596-y.
   PubMed Web of Science ®Google Scholar
• Ok JH, Lee H, Chung H-Y, Lee SH, Choi EJ, Kang CM, Lee SM. The potential use of a ketogenic diet in pancreatobiliary cancer patients after pancreatectomy. Anticancer Res. 2018;38(11):6519–27. doi:10.21873/anticanres.13017.
   PubMed Web of Science ®Google Scholar
• Kang CM, Yun B, Kim M, Song M, Kim Y-H, Lee SH, Lee H, Lee SM, Lee S-M. Postoperative serum metabolites of patients on a low carbohydrate ketogenic diet after pancreatectomy for pancreatobiliary cancer: a nontargeted metabolomics pilot study. Sci Rep. 2019;9(1):16820. doi:10.1038/s41598-019-53287-y.
   PubMed Web of Science ®Google Scholar
• Augustus E, Granderson I, Rocke KD. the impact of a ketogenic dietary intervention on the quality of life of stage II and III cancer patients: a randomized controlled trial in the Caribbean. Nutr Cancer. 2021;73(9):1590–600. doi:10.1080/01635581.2020.1803930
   PubMed Web of Science ®Google Scholar
• Santos JG, Da Cruz WMS, Schönthal AH, Salazar MD, Fontes CAP, Quirico-Santos T, Da Fonseca CO. Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma. Oncol Lett. 2018;15(1):1263–70. doi:10.3892/ol.2017.7362.
   PubMed Web of Science ®Google Scholar
• Budipramana VS, Arifin F. Very low carbohydrate diet effect on modified glasgow prognostic score: A randomized controlled trial on Stage-IV colorectal adenocarcinoma patients. SGO. 2020;25(5):280–5. doi:10.21614/sgo-25-5-280
   Google Scholar
• Klement RJ, Champ CE, Otto C, Kämmerer U. Anti-tumor effects of ketogenic diets in mice: a meta-analysis. PLoS One. 2016;11(5):e0155050. doi:10.1371/journal.pone.0155050.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang H, Dai Z. Cancer treatment with the ketogenic diet: a systematic review and meta-analysis of animal studies. Front Nutr. 2021;8:594408. doi:10.3389/fnut.2021.594408.
   PubMed Web of Science ®Google Scholar
• Klement RJ, Bandyopadhyay PS, Champ CE, Walach H. Application of Bayesian evidence synthesis to modelling the effect of ketogenic therapy on survival of high grade glioma patients. Theor Biol Med Model. 2018;15(1):12. doi:10.1186/s12976-018-0084-y
   PubMed Web of Science ®Google Scholar
• Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23(7):1370–8. doi:10.1200/jco.2005.01.079.
   PubMed Web of Science ®Google Scholar
• Cao Y, Ma J. Body Mass Index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res. 2011;4(4):486–501. doi:10.1158/1940-6207.CAPR-10-0229
   PubMed Web of Science ®Google Scholar
• Schmitz KH, Neuhouser ML, Agurs-Collins T, Zanetti KA, Cadmus-Bertram L, Dean LT, Drake BF. Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst. 2013;105(18):1344–54. doi:10.1093/jnci/djt223.
   PubMedGoogle Scholar
• Yuan C, Bao Y, Wu C, Kraft P, Ogino S, Ng K, Qian ZR, Rubinson DA, Stampfer MJ, Giovannucci EL, et al. Prediagnostic body mass index and pancreatic cancer survival. JCO. 2013;31(33):4229–34. doi:10.1200/JCO.2013.51.7532
   PubMed Web of Science ®Google Scholar
• Malietzis G, Currie AC, Athanasiou T, Johns N, Anyamene N, Glynne-Jones R, Kennedy RH, Fearon KCH, Jenkins JT. Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg. 2016;103(5):572–80. doi:10.1002/bjs.10075.
   PubMed Web of Science ®Google Scholar
• Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, Feliciano EC, Castillo AL, Quesenberry CP, Kwan ML, et al. Explaining the obesity paradox: The association between body composition and colorectal cancer survival (c-scans study). Cancer Epidemiol Biomarkers Prev. 2017;26(7):1008–15. doi:10.1158/1055-9965.EPI-17-0200
   PubMed Web of Science ®Google Scholar
• Deluche E, Leobon S, Desport JC, Venat-Bouvet L, Usseglio J, Tubiana-mathieu N. Impact of body composition on outcome in patients with early breast cancer. Support Care Cancer. 2018;26(3):861–8. doi:10.1007/s00520-017-3902-6.
   PubMed Web of Science ®Google Scholar
• Doyle SL, Donohoe CL, Lysaght J, Reynolds JV. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nutr Soc. 2012;71(1):181–9. doi:10.1017/S002966511100320X.
   PubMed Web of Science ®Google Scholar
• Paoli A, Bosco G, Camporesi EM, Mangar D. Ketosis, ketogenic diet and food intake control: a complex relationship. Front Psychol. 2015;6:27. doi:10.3389/fpsyg.2015.00027.
   PubMed Web of Science ®Google Scholar
• Tisdale MJ, Brennan RA, Fearon KC. Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer. 1987;56(1):39–43. doi:10.1038/bjc.1987.149.
   PubMed Web of Science ®Google Scholar
• Fearon KC, Borland W, Preston T, Tisdale MJ, Shenkin A, Calman KC. Cancer cachexia: influence of systemic ketosis on substrate levels and nitrogen metabolism. Am J Clin Nutr. 1988;47(1):42–8. doi:10.1093/ajcn/47.1.42
   PubMed Web of Science ®Google Scholar
• Shukla SK, Gebregiworgis T, Purohit V, Chaika NV, Gunda V, Radhakrishnan P, Mehla K, Pipinos II, Powers R, Yu F, et al. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab. 2014;2:18. doi:10.1186/2049-3002-2-18.
   PubMedGoogle Scholar
• Rosenbaum M, Hall KD, Guo J, Ravussin E, Mayer LS, Reitman ML, Smith SR, Walsh BT, Leibel RL. Glucose and lipid homeostasis and inflammation in humans following an isocaloric ketogenic diet. Obesity (Silver Spring). 2019;27(6):971–81. doi:10.1002/oby.22468.
   PubMed Web of Science ®Google Scholar
• Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res. 1990;50(1):48–53.
   PubMed Web of Science ®Google Scholar
• Lahm H, Suardet L, Laurent PL, Fischer JR, Ceyhan A, Givel JC, Odartchenko N. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor α. Br J Cancer. 1992;65(3):341–6. doi:10.1038/bjc.1992.69.
   PubMed Web of Science ®Google Scholar
• Iwamura M, Sluss PM, Casamento JB, Cockett AT. Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate. 1993;22(3):243–52. doi:10.1002/pros.2990220307
   PubMed Web of Science ®Google Scholar
• Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. JCO. 2002;20(1):42–51. doi:10.1200/JCO.2002.20.1.42
   PubMed Web of Science ®Google Scholar
• Ferroni P, Riondino S, Laudisi A, Portarena I, Formica V, Alessandroni J, D’Alessandro R, Orlandi A, Costarelli L, Cavaliere F, et al. Pretreatment insulin levels as a prognostic factor for breast cancer progression. Oncologist. 2016;21(9):1041–9. doi:10.1634/theoncologist.2015-0462
   PubMed Web of Science ®Google Scholar
• Fine EJ, Feinman RD. Insulin, carbohydrate restriction, metabolic syndrome and cancer. Exp Rev Endocrin Metab. 2015;10(1):15–24. doi:10.1586/17446651.2014.960392
   PubMed Web of Science ®Google Scholar
• Koutnik AP, Poff AM, Ward NP, DeBlasi JM, Soliven MA, Romero MA, Roberson PA, Fox CD, Roberts MD, D’Agostino DP, et al. Ketone bodies attenuate wasting in models of atrophy. J Cachexia Sarcopenia Muscle. 2020;11(4):973–96. doi:10.1002/jcsm.12554.
   PubMed Web of Science ®Google Scholar
• Miller VJ, Villamena FA, Volek JS. Nutritional ketosis and mitohormesis: potential implications for mitochondrial function and human health. J Nutr Metab. 2018;2018:5157645. doi:10.1155/2018/5157645
   PubMed Web of Science ®Google Scholar
• Urbain P, Bertz H. Monitoring for compliance with a ketogenic diet: what is the best time of day to test for urinary ketosis? Nutr Metab (Lond). 2016;13:77. doi:10.1186/s12986-016-0136-4.
   PubMed Web of Science ®Google Scholar
• Fukazawa A, Karasawa T, Yokota Y, Kondo S, Aoyama T, Terada S. The safety of very-long-term intake of a ketogenic diet containing medium-chain triacylglycerols. J Oleo Sci. 2021;70(7):989–93. doi:10.5650/jos.ess21080.
   PubMed Web of Science ®Google Scholar
• Nebeling LC, Lerner E. Implementing a ketogenic diet based on medium-chain triglyceride oil in pediatric patients with cancer. J Am Diet Assoc. 1995;95(6):693–7. doi:10.1016/S0002-8223(95)00189-1
   PubMedGoogle Scholar
• Martin-McGill KJ, Marson AG, Smith CT, Jenkinson MD. The modified ketogenic diet in adults with glioblastoma: an evaluation of feasibility and deliverability within the National Health Service. Nutr Cancer. 2018;70(4):643–9. doi:10.1080/01635581.2018.1460677.
   PubMed Web of Science ®Google Scholar
• Sürmelıoğlu N, Paydaş S, Karataş Y, Seydaoğlu G. Evaluation of lipid profiles in patients treated with capecitabine. Turk J Med Sci. 2017;47(4):1206–9. doi:10.3906/sag-1607-53.
   PubMed Web of Science ®Google Scholar
• Bar-Sela G, Haim N. Uncontrolled hypertriglyceridemia induced by capecitabine: Case report and review of the literature. Cancer Chemother Pharmacol. 2009;63(5):779–82. doi:10.1007/s00280-008-0799-2.
   PubMed Web of Science ®Google Scholar
• Michie CO, Sakala M, Rivans I, Strachan MWJ, Clive S. The frequency and severity of capecitabine-induced hypertriglyceridaemia in routine clinical practice: a prospective study. Br J Cancer. 2010;103(5):617–21. doi:10.1038/sj.bjc.6605807.
   PubMed Web of Science ®Google Scholar
• Fine EJ, Segal-Isaacson CJ, Feinman RD, Herszkopf S, Romano MC, Tomuta N, Bontempo AF, Negassa A, Sparano JA. Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients. Nutrition. 2012;28(10):1028–35. doi:10.1016/j.nut.2012.05.001.
   PubMed Web of Science ®Google Scholar
• Foppiani A, De Amicis R, Lessa C, Leone A, Ravella S, Ciusani E, et al. Isocaloric ketogenic diet in adults with high-grade gliomas: a prospective metabolic study. Nutr Cancer. 2020;0:1–11. doi:10.1080/01635581.2020.1779759
   Web of Science ®Google Scholar
• RIEGER J, BÄHR O, MAURER GD, HATTINGEN ELKE, FRANZ KEA, BRUCKER D, WALENTA S, KÄMMERER U, COY JF, WELLER M, et al. ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol. 2014;44(6):1843–52. doi:10.3892/ijo.2014.2382
   PubMed Web of Science ®Google Scholar
• Tan-Shalaby JL, Carrick J, Edinger K, Genovese D, Liman AD, Passero VA, Shah RB. Modified Atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System. Nutr Metab (Lond). 2016;13:52. doi:10.1186/s12986-016-0113-y
   PubMed Web of Science ®Google Scholar
• Hagihara K, Kajimoto K, Osaga S, Nagai N, Shimosegawa E, Nakata H, Saito H, Nakano M, Takeuchi M, Kanki H, et al. Promising effect of a new ketogenic diet regimen in patients with advanced cancer. Nutrients. 2020;12(5):1473. doi:10.3390/nu12051473
   PubMed Web of Science ®Google Scholar
• Schroeder U, Himpe B, Pries R, Vonthein R, Nitsch S, Wollenberg B. Decline of lactate in tumor tissue after ketogenic diet: in vivo microdialysis study in patients with head and neck cancer. Nutr Cancer. 2013;65(6):843–9. doi:10.1080/01635581.2013.804579.
   PubMed Web of Science ®Google Scholar
• Westman EC, Mavropoulos J, Yancy WS, Volek JS. A review of low-carbohydrate ketogenic diets. Curr Atheroscler Rep. 2003;5(6):476–83. doi:10.1007/s11883-003-0038-6
   PubMedGoogle Scholar
• Bandyopadhyay PS, Brittan G, Jr, Taper ML. Belief, evidence, and uncertainty: problems of epistemic inference. 1st ed. Basel: Springer International Publishing; 2016. doi:10.1007/978-3-319-27772-1
   Google Scholar
• Khodabakhshi A. The evidence of ketogenic diet in the treatment of cancer. J Isfahan Med School 2021;39(631):492–5.
   Google Scholar
• Khodabakhshi A, Seyfried TN, Kalamian M, Davoodi SH. Answer to the critical remarks to the article by Khodabakhshi and colleagues reporting results from a randomized study on ketogenic diet. Clinical Nutrition 2022.
   PubMed Web of Science ®Google Scholar